University of Texas/MD Anderson Cancer Center MD Anderson 2 — Houston, Texas

University of Texas/MD Anderson Cancer Center MD Anderson 2 is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas/MD Anderson Cancer Center MD Anderson 2 has participated in 1 clinical trials.

Therapeutic areas: Pancreatic Cancer, BRAF Mutant Colorectal Cancer, Melanoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas/MD Anderson Cancer Center MD Anderson 2?

University of Texas/MD Anderson Cancer Center MD Anderson 2 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas/MD Anderson Cancer Center MD Anderson 2 conducted?

University of Texas/MD Anderson Cancer Center MD Anderson 2 has 1 clinical trials on record. Their work covers Pancreatic Cancer, BRAF Mutant Colorectal Cancer, Melanoma.

Is University of Texas/MD Anderson Cancer Center MD Anderson 2 accredited by Crixeo Health?

University of Texas/MD Anderson Cancer Center MD Anderson 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas/MD Anderson Cancer Center MD Anderson 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.